Direct Healthcare 24 Plc - Limited company accounts 17.3

Direct Healthcare 24 Plc - Limited company accounts 17.3


IRIS Accounts Production v17.3.1.106 08741677 Board of Directors 1.10.16 30.9.17 30.9.17 recruitment agency. false true true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure087416772016-09-30087416772017-09-30087416772016-10-012017-09-30087416772015-09-30087416772015-10-012016-09-30087416772016-09-3008741677ns15:EnglandWales2016-10-012017-09-3008741677ns14:PoundSterling2016-10-012017-09-3008741677ns10:Director12016-10-012017-09-3008741677ns10:PublicLimitedCompanyPLC2016-10-012017-09-3008741677ns10:FRS1022016-10-012017-09-3008741677ns10:Audited2016-10-012017-09-3008741677ns10:LargeMedium-sizedCompaniesRegimeForDirectorsReport2016-10-012017-09-3008741677ns10:LargeMedium-sizedCompaniesRegimeForAccounts2016-10-012017-09-3008741677ns10:FullAccounts2016-10-012017-09-3008741677ns10:OrdinaryShareClass12016-10-012017-09-3008741677ns10:Director22016-10-012017-09-3008741677ns10:Director32016-10-012017-09-3008741677ns10:Director42016-10-012017-09-3008741677ns10:Director62016-10-012017-09-3008741677ns10:CompanySecretary12016-10-012017-09-3008741677ns10:RegisteredOffice2016-10-012017-09-3008741677ns10:Director52016-10-012017-09-3008741677ns5:CurrentFinancialInstruments2017-09-3008741677ns5:CurrentFinancialInstruments2016-09-3008741677ns5:ShareCapital2017-09-3008741677ns5:ShareCapital2016-09-3008741677ns5:CapitalRedemptionReserve2017-09-3008741677ns5:CapitalRedemptionReserve2016-09-3008741677ns5:RetainedEarningsAccumulatedLosses2017-09-3008741677ns5:RetainedEarningsAccumulatedLosses2016-09-3008741677ns5:ShareCapital2015-09-3008741677ns5:RetainedEarningsAccumulatedLosses2015-09-3008741677ns5:CapitalRedemptionReserve2015-09-3008741677ns5:RetainedEarningsAccumulatedLosses2015-10-012016-09-3008741677ns5:CapitalRedemptionReserve2015-10-012016-09-3008741677ns5:ShareCapital2016-10-012017-09-3008741677ns5:CapitalRedemptionReserve2016-10-012017-09-3008741677ns5:ComputerEquipment2016-10-012017-09-3008741677ns5:OwnedAssets2016-10-012017-09-3008741677ns5:OwnedAssets2015-10-012016-09-3008741677ns5:ComputerEquipment2016-09-3008741677ns5:ComputerEquipment2017-09-3008741677ns5:ComputerEquipment2016-09-3008741677ns10:OrdinaryShareClass12017-09-3008741677ns5:RetainedEarningsAccumulatedLosses2016-09-3008741677ns5:CapitalRedemptionReserve2016-09-3008741677ns5:RetainedEarningsAccumulatedLosses2016-10-012017-09-30


REGISTERED NUMBER: 08741677 (England and Wales)















Strategic Report, Report of the Directors and

Financial Statements for the Year Ended 30 September 2017

for

Direct Healthcare 24 Plc

Direct Healthcare 24 Plc (Registered number: 08741677)






Contents of the Financial Statements
for the Year Ended 30 September 2017




Page

Company Information 1

Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 5

Income Statement 7

Other Comprehensive Income 8

Balance Sheet 9

Statement of Changes in Equity 10

Cash Flow Statement 11

Notes to the Cash Flow Statement 12

Notes to the Financial Statements 13


Direct Healthcare 24 Plc

Company Information
for the Year Ended 30 September 2017







DIRECTORS: K Coyle
C Coyle
D Harrington
N Poturicich
Ms A L Cooper





SECRETARY: H Pepperdine





REGISTERED OFFICE: Hygeia House
66-68 College Road
Harrow
Middlesex
HA1 1BE





REGISTERED NUMBER: 08741677 (England and Wales)





AUDITORS: SHERIDAN CLARKE LTD
STATUTORY AUDITORS
BRIDGE HOUSE
25-27 THE BRIDGE
HARROW
HA3 5AB

Direct Healthcare 24 Plc (Registered number: 08741677)

Strategic Report
for the Year Ended 30 September 2017

The directors present their strategic report for the year ended 30 September 2017.

REVIEW OF BUSINESS
The Directors consider the profit on ordinary activities before taxation to be satisfactory despite a reduction in turnover
and gross profit margin on the prior year.


The key financial highlights for the period are as follows:

2017 2016 2015

Turnover £1,342,787 £1,613,820 £2,075,028

Gross profit margin 31% 35% 37%

Profit before tax 26% 22% 23%

PRINCIPAL RISKS AND UNCERTAINTIES
Direct Healthcare 24 Plc continues to progress and has diversified it's activities to mainly provide staff to the healthcare
sector. Adequate finance is in place to take advantage of future business opportunities and the Directors continue to
monitor cash flow and costs to ensure stability and the profit levels of the business.

It is not considered necessary for an understanding of the development, performance or position of the company's
business to comment here on environmental matters, the entity's employees or social, community and human rights
issues. However, the company is very much aware and respectful of such matters and takes them in to account when
planning and implementing business policy and procedures.

ON BEHALF OF THE BOARD:





D Harrington - Director


23 March 2018

Direct Healthcare 24 Plc (Registered number: 08741677)

Report of the Directors
for the Year Ended 30 September 2017

The directors present their report with the financial statements of the company for the year ended 30 September 2017.

DIVIDENDS
No dividends will be distributed for the year ended 30 September 2017.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 October 2016 to the date of this
report.

K Coyle
C Coyle
D Harrington
N Poturicich
Ms A L Cooper

Other changes in directors holding office are as follows:

C Safapour - resigned 27 January 2017

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements
in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors
have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting
Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not
approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the
company and of the profit or loss of the company for that period. In preparing these financial statements, the directors
are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-state whether applicable accounting standards have been followed, subject to any material departures disclosed and
explained in the financial statements;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will
continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the
company's transactions and disclose with reasonable accuracy at any time the financial position of the company and
enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for
safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud
and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act
2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have
taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the
company's auditors are aware of that information.

Direct Healthcare 24 Plc (Registered number: 08741677)

Report of the Directors
for the Year Ended 30 September 2017


AUDITORS
The auditors, SHERIDAN CLARKE LTD, will be proposed for re-appointment at the forthcoming Annual General
Meeting.

ON BEHALF OF THE BOARD:





D Harrington - Director


23 March 2018

Report of the Independent Auditors to the Members of
Direct Healthcare 24 Plc

Opinion
We have audited the financial statements of Direct Healthcare 24 Plc (the 'company') for the year ended
30 September 2017 on pages seven to fifteen. The financial reporting framework that has been applied in their
preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102
'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted
Accounting Practice).

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the
Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those
matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent
permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's
members as a body, for our audit work, for this report, or for the opinions we have formed.

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 30 September 2017 and of its profit for the year
then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law.
Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the
financial statements section of our report. We are independent of the company in accordance with the ethical
requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard,
and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit
evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
We have nothing to report in respect of the following matters in relation to which the ISAs (UK) require us to report to
you where:
- the directors' use of the going concern basis of accounting in the preparation of the financial statements is not
appropriate; or
- the directors have not disclosed in the financial statements any identified material uncertainties that may cast
significant doubt about the company's ability to continue to adopt the going concern basis of accounting for a period
of at least twelve months from the date when the financial statements are authorised for issue.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic
Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors
thereon.

Our opinion on the financial statements does not cover the other information and we do not express any form of
assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing
so, consider whether the other information is materially inconsistent with the financial statements or our knowledge
obtained in the audit or otherwise appears to be materially misstated. If, based on the work we have performed, we
conclude that there is a material misstatement of this other information, we are required to report that fact. We have
nothing to report in this regard.

Opinion on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the
financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal
requirements.

Report of the Independent Auditors to the Members of
Direct Healthcare 24 Plc


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit,
we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you
if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from
branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are
responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and
for such internal control as the directors determine necessary to enable the preparation of financial statements that are
free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a
going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of
accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic
alternative but to do so.

Our responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from
material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion.
Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs
(UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are
considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic
decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting
Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.




Anna Clarke (Senior Statutory Auditor)
for and on behalf of SHERIDAN CLARKE LTD
STATUTORY AUDITORS
BRIDGE HOUSE
25-27 THE BRIDGE
HARROW
HA3 5AB

23 March 2018

Direct Healthcare 24 Plc (Registered number: 08741677)

Income Statement
for the Year Ended 30 September 2017

30.9.17 30.9.16
Notes £    £   

TURNOVER 1,342,787 1,613,820

Cost of sales 923,625 1,043,215
GROSS PROFIT 419,162 570,605

Administrative expenses 73,613 224,748
OPERATING PROFIT 4 345,549 345,857

Interest receivable and similar income 1,197 1,315
PROFIT BEFORE TAXATION 346,746 347,172

Tax on profit 5 67,694 69,554
PROFIT FOR THE FINANCIAL YEAR 279,052 277,618

Direct Healthcare 24 Plc (Registered number: 08741677)

Other Comprehensive Income
for the Year Ended 30 September 2017

30.9.17 30.9.16
Notes £    £   

PROFIT FOR THE YEAR 279,052 277,618


OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

279,052

277,618

Direct Healthcare 24 Plc (Registered number: 08741677)

Balance Sheet
30 September 2017

30.9.17 30.9.16
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 6 2,111 2,814

CURRENT ASSETS
Debtors 7 10,002 123,921
Cash at bank 974,589 784,556
984,591 908,477
CREDITORS
Amounts falling due within one year 8 120,826 124,743
NET CURRENT ASSETS 863,765 783,734
TOTAL ASSETS LESS CURRENT
LIABILITIES

865,876

786,548

CAPITAL AND RESERVES
Called up share capital 9 75,000 100,000
Capital redemption reserve 10 (174,724 ) -
Retained earnings 10 965,600 686,548
SHAREHOLDERS' FUNDS 865,876 786,548

The financial statements were approved by the Board of Directors on 23 March 2018 and were signed on its behalf by:





D Harrington - Director


Direct Healthcare 24 Plc (Registered number: 08741677)

Statement of Changes in Equity
for the Year Ended 30 September 2017

Called up Capital
share Retained redemption Total
capital earnings reserve equity
£    £    £    £   

Balance at 1 October 2015 100,000 408,930 - 508,930

Changes in equity
Total comprehensive income - 277,618 - 277,618
Balance at 30 September 2016 100,000 686,548 - 786,548

Changes in equity
Issue of share capital (25,000 ) - - (25,000 )
Total comprehensive income - 279,052 (174,724 ) 104,328
Balance at 30 September 2017 75,000 965,600 (174,724 ) 865,876

Direct Healthcare 24 Plc (Registered number: 08741677)

Cash Flow Statement
for the Year Ended 30 September 2017

30.9.17 30.9.16
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 469,114 452,538
Tax paid (80,554 ) (122,596 )
Net cash from operating activities 388,560 329,942

Cash flows from investing activities
Purchase of tangible fixed assets - (1,876 )
Interest received 1,197 1,315
Net cash from investing activities 1,197 (561 )

Cash flows from financing activities
Capital repayments in year (174,724 ) -
Share issue (25,000 ) -
Net cash from financing activities (199,724 ) -

Increase in cash and cash equivalents 190,033 329,381
Cash and cash equivalents at beginning of
year

2

784,556

455,175

Cash and cash equivalents at end of year 2 974,589 784,556

Direct Healthcare 24 Plc (Registered number: 08741677)

Notes to the Cash Flow Statement
for the Year Ended 30 September 2017

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM
OPERATIONS
30.9.17 30.9.16
£    £   
Profit before taxation 346,746 347,172
Depreciation charges 703 938
Finance income (1,197 ) (1,315 )
346,252 346,795
Decrease in trade and other debtors 113,919 109,217
Increase/(decrease) in trade and other creditors 8,943 (3,474 )
Cash generated from operations 469,114 452,538

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these
Balance Sheet amounts:

Year ended 30 September 2017
30.9.17 1.10.16
£    £   
Cash and cash equivalents 974,589 784,556
Year ended 30 September 2016
30.9.16 1.10.15
£    £   
Cash and cash equivalents 784,556 455,175

Direct Healthcare 24 Plc (Registered number: 08741677)

Notes to the Financial Statements
for the Year Ended 30 September 2017

1. STATUTORY INFORMATION

Direct Healthcare 24 Plc is a private company , registered in England and Wales. The company's registered
number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover comprises the invoiced value of services supplied by the company, all revenue is recognised in the
Financial Statements as soon as the service has been supplied.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 25% on reducing balance

Taxation
Current tax, including UK Corporation tax is provided at amounts expected to be paid using the tax rates and
laws enacted by the Balance Sheet date.

Deferred tax is only provided for when material. The Directors have decided that deferred tax is once again not
material this year.

3. EMPLOYEES AND DIRECTORS
30.9.17 30.9.16
£    £   
Wages and salaries 39,811 149,196
Social security costs 2,673 14,402
42,484 163,598
The average monthly number of employees during the year was as follows:
30.9.17 30.9.16

Sales 2 6
Admin 1 1
3 7

30.9.17 30.9.16
£    £   
Directors' remuneration - -

4. OPERATING PROFIT

The operating profit is stated after charging:

30.9.17 30.9.16
£    £   
Depreciation - owned assets 703 938
Auditors' remuneration 2,500 3,600

Direct Healthcare 24 Plc (Registered number: 08741677)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2017

5. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
30.9.17 30.9.16
£    £   
Current tax:
UK corporation tax 67,694 69,554
Tax on profit 67,694 69,554

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is
explained below:

30.9.17 30.9.16
£    £   
Profit before tax 346,746 347,172
Profit multiplied by the standard rate of corporation tax in the UK of
19.500% (2016 - 20%)

67,615

69,434

Effects of:
Expenses not deductible for tax purposes 79 120
Total tax charge 67,694 69,554

6. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 October 2016
and 30 September 2017 5,211
DEPRECIATION
At 1 October 2016 2,397
Charge for year 703
At 30 September 2017 3,100
NET BOOK VALUE
At 30 September 2017 2,111
At 30 September 2016 2,814

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.17 30.9.16
£    £   
Trade debtors 10,002 123,921

Direct Healthcare 24 Plc (Registered number: 08741677)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2017

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.17 30.9.16
£    £   
Trade creditors - 219
Tax 32,694 45,554
Social security and other taxes 13,059 6,563
Other creditors 72,573 66,407
Accrued expenses 2,500 6,000
120,826 124,743

9. CALLED UP SHARE CAPITAL


Allotted, issued and fully paid:
Number: Class: Nominal 30.9.17 30.9.16
value: £    £   
100,000 Ordinary £1 75,000 100,000

10. RESERVES
Capital
Retained redemption
earnings reserve Totals
£    £    £   

At 1 October 2016 686,548 - 686,548
Profit for the year 279,052 279,052
Purchase of own shares - (174,724 ) (174,724 )
At 30 September 2017 965,600 (174,724 ) 790,876

11. RELATED PARTY DISCLOSURES

K. Coyle, D. Harrington and A. Cooper are also Directors of Coyle Personnel Plc and Mayday Healthcare Plc.
C. Coyle and N. Poturicich are also Directors of Mayday Healthcare Plc.

No trading took place between the related party companies and no one shareholder holds a controlling interest in
the company.